Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

GALT Galectin Therapeutics Inc

1,99

0,00 (0,00%)

13 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Galectin Therapeutics Charts.

Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Galectin Therapeutics Charts.

News Galectin Therapeutics Inc

Form ARS - Annual Report to Security Holders
Dienstag 3 Dezember 2024 (1 Woche vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Dienstag 3 Dezember 2024 (1 Woche vor) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Dienstag 3 Dezember 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 14 November 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 14 November 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 14 November 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 23 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 17 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 16 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 4 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 9 September 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 26 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere Galectin Therapeutics Inc News-Artikel

Deutsche Telekom

Invesco QQQ Trust Series 1

JP Morgan Chase

Euro vs US Dollar

Health Care Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen